NO20040913L - Nye 2,4-diaminotiazolderivater - Google Patents

Nye 2,4-diaminotiazolderivater

Info

Publication number
NO20040913L
NO20040913L NO20040913A NO20040913A NO20040913L NO 20040913 L NO20040913 L NO 20040913L NO 20040913 A NO20040913 A NO 20040913A NO 20040913 A NO20040913 A NO 20040913A NO 20040913 L NO20040913 L NO 20040913L
Authority
NO
Norway
Prior art keywords
new
diaminothiazole
derivatives
diaminothiazole derivatives
Prior art date
Application number
NO20040913A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew Neil Bowler
Bo Falck Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2002/000508 external-priority patent/WO2003011843A1/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20040913L publication Critical patent/NO20040913L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20040913A 2001-08-03 2004-03-02 Nye 2,4-diaminotiazolderivater NO20040913L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101175 2001-08-03
PCT/DK2002/000508 WO2003011843A1 (en) 2001-08-03 2002-07-22 Novel 2,4-diaminothiazole derivatives

Publications (1)

Publication Number Publication Date
NO20040913L true NO20040913L (no) 2004-04-01

Family

ID=32921515

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040913A NO20040913L (no) 2001-08-03 2004-03-02 Nye 2,4-diaminotiazolderivater

Country Status (11)

Country Link
US (1) US20040210063A1 (pl)
KR (1) KR20040029393A (pl)
CN (1) CN1547574A (pl)
BR (1) BR0211626A (pl)
CO (1) CO5560564A2 (pl)
EA (1) EA200400260A1 (pl)
IL (1) IL159965A0 (pl)
IS (1) IS7131A (pl)
NO (1) NO20040913L (pl)
PL (1) PL368536A1 (pl)
ZA (1) ZA200400733B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2673368C (en) * 2006-12-19 2014-10-28 The Board Of Trustees Of The University Of Illinois 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
WO2013142509A1 (en) * 2012-03-19 2013-09-26 Isis Pharmaceuticals, Inc. ANTISENSE MODULATION OF HYPOXIA INDUCIBLE FACTOR 1 ALPHA (HIFIα) EXPRESSION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214852B1 (en) * 1998-10-21 2001-04-10 Bristol-Myers Squibb Company N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases

Also Published As

Publication number Publication date
CN1547574A (zh) 2004-11-17
EA200400260A1 (ru) 2004-06-24
IS7131A (is) 2004-01-29
KR20040029393A (ko) 2004-04-06
BR0211626A (pt) 2004-08-24
ZA200400733B (en) 2004-08-24
IL159965A0 (en) 2004-06-20
US20040210063A1 (en) 2004-10-21
CO5560564A2 (es) 2005-09-30
PL368536A1 (pl) 2005-04-04

Similar Documents

Publication Publication Date Title
NO20035428D0 (no) Nye anti-ineffektiver
DE60216115D1 (de) BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
NO20034970D0 (no) Nye arylheteroalkylaminderivater
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
NO20040014L (no) Nye forbindelser
NO20041003L (no) Nye forbindelser
NO20034665L (no) Nye forbindelser
NO20026064L (no) Nye forbindelser
NO20023933L (no) Nye forbindelser
EE05386B1 (et) Ftalasinoon-piperidinoderivaadid,ÁnendeÁkasutamineÁjaÁravim
NO20020810L (no) Nye fenylpiperaziner
NO20025151D0 (no) Nye forbindelser
NO20031141D0 (no) Nye forbindelser
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20040066L (no) Nye antikonvulsivaderivater
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20026162L (no) Nye forbindelser
NO20041185L (no) Nye sykloheksylsulfoner
NO20030274D0 (no) Nye aryleten-sulfonamider
NO20026081D0 (no) Nye forbindelser
NO20030657D0 (no) Nye aminocykloheksanderivater
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater